Molecular Partners Ag (MOLN) Other Non-Current Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Other Non-Current Liabilities of $2458.2 for Q1 2026, down 7.76% year-on-year from $2665.0 in Q1 2025, and up 11.19% on a QoQ basis from $2210.8 in Q4 2025.

Molecular Partners Ag (MOLN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Other Non-Current Liabilities for 7 consecutive years, with $2458.2 the latest figure, recorded in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 7.76% year-over-year to $2458.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2458.2 (down 7.76% YoY) and the FY2025 annual result came in at $2210.8, changed N/A from the prior year.
  • Other Non-Current Liabilities climbed to $2458.2 in Q1 2026 per MOLN's latest filing, from $2210.8 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for MOLN reached as high as $5.8 million in Q2 2022 and fell as low as $1497.1 in Q4 2023.
  • A 5-year average of $750284.3 and a median of $2707.1 in 2025 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Other Non-Current Liabilities increased 18.94% — and 2025, when it tumbled 99.92%.
  • Year by year, Other Non-Current Liabilities stood at $2224.5 in 2022, then plunged by 32.7% to $1497.1 in 2023, then surged by 83.64% to $2749.3 in 2024, then slipped by 19.59% to $2210.8 in 2025, then gained by 11.19% to $2458.2 in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $2458.2, $2210.8, and $2654.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Molecular Partners Ag 147.97 Mn 147.97 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2,458.23
Dec 31, 2025 2,210.82
Sep 30, 2025 2,653.98
Jun 30, 2025 2,380.75
Mar 31, 2025 2,664.95
Sep 30, 2024 2,749.32
Jun 30, 2024 3.16 Mn
Mar 31, 2024 3,676.49
Dec 31, 2023 1,497.13
Sep 30, 2023 2,380.92
Jun 30, 2023 3.05 Mn
Mar 31, 2023 3,091.04
Dec 31, 2022 2,224.48
Sep 30, 2022 3,539.19
Jun 30, 2022 5.76 Mn
Mar 31, 2022 4,926.78
Dec 31, 2021 8,013.39
Sep 30, 2021 4,136.51
Dec 31, 2020 6,443.36